4//SEC Filing
LANE ANDREW H 4
Accession 0001179110-19-007717
CIK 0000001800other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 5:03 PM ET
Size
9.6 KB
Accession
0001179110-19-007717
Insider Transaction Report
Form 4
LANE ANDREW H
Senior Vice President
Transactions
- Exercise/Conversion
Common shares without par value
2019-06-12$48.90/sh+73,424$3,590,434→ 119,362 total - Sale
Common shares without par value
2019-06-12$81.42/sh−73,424$5,978,197→ 45,938 total - Exercise/Conversion
Option (right to buy)
2019-06-12−73,424→ 41,268 totalExercise: $48.90From: 2018-06-01Exp: 2025-05-31→ Common shares (73,424 underlying)
Holdings
- 1,262(indirect: By Trust)
Common shares without par value
Footnotes (4)
- [F1]Includes shares acquired pursuant to a dividend reinvestment feature.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.41 to $81.505, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Balance in the Abbott Laboratories Stock Retirement Trust as of June 13, 2019.
- [F4]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001643735
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 5:03 PM ET
- Size
- 9.6 KB